Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Description
Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer?
Credit available for this activity expires: 11/20/23
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998605?ecd=bdc_podcast_libsyn_mscpedu
What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them?
Credit available for this activity expires: 06/28/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/28/24
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/27/24